Publication: Angiogenesis in stage IIIB squamous cell carcinoma of uterine cervix: Reproducibility of measurement and preliminary outcome as a prognostic factor
Issued Date
2004-07-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-4444370971
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.87, No.7 (2004), 794-799
Suggested Citation
Janjira Petsuksiri, Tuenjai Chuangsuwanich, Pittayapoom Pattaranutaporn, Samornmas Kanngurn Angiogenesis in stage IIIB squamous cell carcinoma of uterine cervix: Reproducibility of measurement and preliminary outcome as a prognostic factor. Journal of the Medical Association of Thailand. Vol.87, No.7 (2004), 794-799. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/21613
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Angiogenesis in stage IIIB squamous cell carcinoma of uterine cervix: Reproducibility of measurement and preliminary outcome as a prognostic factor
Other Contributor(s)
Abstract
This study was performed to determine the reliability and replicability of IMD analysis using the Factor VIII immunohistochemical method The following purpose was determining the relationship between IMD and clinical outcome in individual cervical cancer patient treated with radical radiotherapy. Twenty nine patients with stage IIIB cervical cancer were enrolled. Phase one was performed by using two pieces of tissue biopsy from different locations in the tumor from each patient. The IMD value was counted by the two pathologists after counterstaining by Factor VIII immunohistochemical method No interobserver disagreement between the two pathologists was found (correlation coefficient = 0.92, 95% CI 0.82-0.96 for the first piece of tissue and 0.85, 95% CI 0.67-0.93 for the second piece). There was no variability in the IMD between the 2 pieces of tissue specimens from different locations of the tumor. Phase two followed to evaluate the relationship between IMD and clinical outcome in individual cervical cancer patients. Because of the small sample size, different patients' characteristics, different treatment protocol and short term follow up, there is no statistically significant conclusion.